Clinical Trials

Blue Faery



Clinical Trials

Print Friendly

Clinical trials are studies conducted on volunteers using investigational treatments or methods. The decision to enroll in a trial should be based on concrete information and eligibility depends on many factors. For more information about HCC clinical trials in your area, visit

  • Discuss the advantages, disadvantages and side effects of treatment options with your doctor.
  • Ask your doctor about the possibility of using experimental therapies and eligibility to participate in clinical trials. If you want to participate in clinical trial, ask what is the phase of the trial.
  • Consider seeking a second opinion if your health insurance allows you the option to do so.

Liver Cancer Clinical Trials

A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib*

This study is investigating a therapy called cabozantinib for the treatment of advanced hepatocellular carcinoma, the most common form of liver cancer, in adults whose disease has spread or grown after treatment with the medication sorafenib. The main purpose of the CELESTIAL trial is to determine whether cabozantinib can improve patient survival.

Condition: Hepatocellular carcinoma
Intervention: Cabozantinib
Phase: 3
Study Type: Interventional
Study Design: Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment

For more information, email or call 1-855-292-3935

Exelisis, Inc
Lindsay Treadway, Director, Public Affairs and Advocacy Relations
210 East Grand Avenue
South San Francisco, CA 94080
United States
Map It
Phone: (650) 837-7522

*Disclosure: This clinical trial is a paid listing.

Scroll Up